TipRanks
Go Ultimate55% OFF

Oncopeptides AB (ONCO) Balance Sheet

Oncopeptides AB Balance Sheet

Oncopeptides AB's total assets for Q2 2026 were $222.01M, a decrease of 18.35% from the previous quarter. SE:ONCO total liabilities were $197.09M for the fiscal quarter, a 1.01% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 134.84M$ 244.19M$ 238.38M$ 385.32M$ 439.38M
$ 193.73M$ 189.91M$ 181.60M$ 91.03M$ 228.51M
$ -58.89M$ 54.28M$ 56.78M$ 294.29M$ 210.87M

Currency in SEK

Oncopeptides AB Debt to Assets

0400M800M1.2B0 %60 %120 %180 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets